Pulmonary fibrosis with persistent physiological deficit is a previously described feature of patients recovering from coronaviruses. Long-term health consequences of COVID-19 are still largely unknown. We aimed to evaluate whether CT abnormalities persist in COVID-19 survivors three months after discharge, and whether the amount of affected lung tissue correlates with pulmonary and physical function. Therefore, we evaluated patients three months after discharge at our outpatient clinic. All patients underwent pulmonary function testing, high resolution chest CT, six-minute walk test and handgrip strength test. We compared severely ill patients to moderately ill patients, whom respectively received treatment at the Intensive Care Unit and the general ward. In total 84 patients were included with a median age of 61·4±12·9 years of whom 53 were male. 50 patients had moderate disease and 34 were severely ill. 66 patients had residual abnormalities on follow-up chest CT. Reticulation and curvilinear bands were more frequent in severely ill patients (resp. 21% vs 4%; p=0·029 and 55% vs 23%; p=0·004). DLCOc, FEV1 and FVC in percentage of predicted were lower in severely ill patients. Severely ill patients were more likely to show an abnormal 6MWT, lower HGS and lower self-reported ADL and condition. In conclusion, in patients recovering from COVID-19, residual abnormalities were frequently present three months after hospitalization and associated with impaired pulmonary and physical function. This association was even stronger in patients who had been admitted to the ICU.
Published in | Journal of Health and Environmental Research (Volume 7, Issue 3) |
DOI | 10.11648/j.jher.20210703.15 |
Page(s) | 145-153 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2021. Published by Science Publishing Group |
COVID-19, Long-COVID, Multidisciplinary Follow-up, Outpatient Clinic, Pulmonary Function
[1] | World Health Organization. WHO Coronavirus disease (COVID-19) Dashboard. https://covid19.who.int. Published on June 9th 2021. |
[2] | De Graaf, M. A., et al., Short-term outpatient follow-up of COVID-19 patients: A multidisciplinary approach. EClinicalMedicine, 2021: p. 100731. |
[3] | Van den Borst, B., et al., Comprehensive health assessment three months after recovery from acute COVID-19. Clin Infect Dis, 2020. |
[4] | Huang, C., et al., 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet, 2021. 397 (10270): p. 220-232. |
[5] | Hui, D. S., et al., Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax, 2005. 60 (5): p. 401-9. |
[6] | Das, K. M., et al., Follow-up chest radiographic findings in patients with MERS-CoV after recovery. Indian J Radiol Imaging, 2017. 27 (3): p. 342-349. |
[7] | Mandal, S., et al., 'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax, 2020. |
[8] | Carfi, A., et al., Persistent Symptoms in Patients After Acute COVID-19. JAMA, 2020. 324 (6): p. 603-605. |
[9] | Nalbandian, A., et al., Post-acute COVID-19 syndrome. Nat Med, 2021. 27 (4): p. 601-615. |
[10] | Prokop, M., et al., CO-RADS: A Categorical CT Assessment Scheme for Patients Suspected of Having COVID-19-Definition and Evaluation. Radiology, 2020. 296 (2): p. E97-E104. |
[11] | Simpson, C. R., et al., The UK's pandemic influenza research portfolio: a model for future research on emerging infections. Lancet Infect Dis, 2019. 19 (8): p. e295-e300. |
[12] | Graham BL, Steenbruggen I, Miller MR et al. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med. 2019; 200 (8): e70-e88. |
[13] | Holland, A. E., et al., An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J, 2014. 44 (6): p. 1428-46. |
[14] | Ali, N. A., et al., Acquired weakness, handgrip strength, and mortality in critically ill patients. Am J Respir Crit Care Med, 2008. 178 (3): p. 261-8. |
[15] | Enright, P. L. and D. L. Sherrill, Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med, 1998. 158 (5 Pt 1): p. 1384-7. |
[16] | Dodds, R. M., et al., Grip strength across the life course: normative data from twelve British studies. PLoS One, 2014. 9 (12): p. e113637. |
[17] | Balbi, M., et al., Post-discharge chest CT findings and pulmonary function tests in severe COVID-19 patients. Eur J Radiol, 2021. 138: p. 109676. |
[18] | Herridge, M. S., et al., One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med, 2003. 348 (8): p. 683-93. |
[19] | Grasselli, G., et al., Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study. Lancet Respir Med, 2020. 8 (12): p. 1201-1208. |
[20] | Desai, S. R., et al., Acute respiratory distress syndrome: CT abnormalities at long-term follow-up. Radiology, 1999. 210 (1): p. 29-35. |
[21] | Group, R. C., et al., Dexamethasone in Hospitalized Patients with COVID-19. N Engl J Med, 2021. 384 (8): p. 693-704. |
[22] | Klok, F. A., et al., Diagnosis of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Eur Respir J, 2020. 55 (6). |
[23] | Huisman, M. V., et al., Pulmonary embolism. Nat Rev Dis Primers, 2018. 4: p. 18028. |
[24] | Dutch, C., et al., Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave. Thromb Res, 2021. 199: p. 143-148. |
[25] | Lam, M. H., et al., Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med, 2009. 169 (22): p. 2142-7. |
[26] | Kress, J. P. and J. B. Hall, ICU-acquired weakness and recovery from critical illness. N Engl J Med, 2014. 371 (3): p. 287-8. |
[27] | Myall, K. J., et al., Persistent Post-COVID-19 Inflammatory Interstitial Lung Disease: An Observational Study of Corticosteroid Treatment. Ann Am Thorac Soc, 2021. |
[28] | Drake, T. M., et al., Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study. Am J Respir Crit Care Med, 2020. 202 (12): p. 1656-1665. |
[29] | Esposito, A. J., et al., Increased Odds of Death for Patients with Interstitial Lung Disease and COVID-19: A Case-Control Study. Am J Respir Crit Care Med, 2020. 202 (12): p. 1710-1713. |
APA Style
Bas Floris Maria Van Raaij, Jordy Lauran Stöger, Maarten Sebastiaan Werkman, Michiel Alexander De Graaf, Maria Louisa Antoni, et al. (2021). Analysis of Pulmonary and Physical Function Three Months After Discharge for Moderate to Severe COVID-19. Journal of Health and Environmental Research, 7(3), 145-153. https://doi.org/10.11648/j.jher.20210703.15
ACS Style
Bas Floris Maria Van Raaij; Jordy Lauran Stöger; Maarten Sebastiaan Werkman; Michiel Alexander De Graaf; Maria Louisa Antoni, et al. Analysis of Pulmonary and Physical Function Three Months After Discharge for Moderate to Severe COVID-19. J. Health Environ. Res. 2021, 7(3), 145-153. doi: 10.11648/j.jher.20210703.15
AMA Style
Bas Floris Maria Van Raaij, Jordy Lauran Stöger, Maarten Sebastiaan Werkman, Michiel Alexander De Graaf, Maria Louisa Antoni, et al. Analysis of Pulmonary and Physical Function Three Months After Discharge for Moderate to Severe COVID-19. J Health Environ Res. 2021;7(3):145-153. doi: 10.11648/j.jher.20210703.15
@article{10.11648/j.jher.20210703.15, author = {Bas Floris Maria Van Raaij and Jordy Lauran Stöger and Maarten Sebastiaan Werkman and Michiel Alexander De Graaf and Maria Louisa Antoni and Geert Hendrik Groeneveld and Anna Helena Elvire Roukens and Frederikus Albertus Klok and Soerindra Rajen Soeniel Ramai and Jacomina Jessica Miranda Geelhoed}, title = {Analysis of Pulmonary and Physical Function Three Months After Discharge for Moderate to Severe COVID-19}, journal = {Journal of Health and Environmental Research}, volume = {7}, number = {3}, pages = {145-153}, doi = {10.11648/j.jher.20210703.15}, url = {https://doi.org/10.11648/j.jher.20210703.15}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.jher.20210703.15}, abstract = {Pulmonary fibrosis with persistent physiological deficit is a previously described feature of patients recovering from coronaviruses. Long-term health consequences of COVID-19 are still largely unknown. We aimed to evaluate whether CT abnormalities persist in COVID-19 survivors three months after discharge, and whether the amount of affected lung tissue correlates with pulmonary and physical function. Therefore, we evaluated patients three months after discharge at our outpatient clinic. All patients underwent pulmonary function testing, high resolution chest CT, six-minute walk test and handgrip strength test. We compared severely ill patients to moderately ill patients, whom respectively received treatment at the Intensive Care Unit and the general ward. In total 84 patients were included with a median age of 61·4±12·9 years of whom 53 were male. 50 patients had moderate disease and 34 were severely ill. 66 patients had residual abnormalities on follow-up chest CT. Reticulation and curvilinear bands were more frequent in severely ill patients (resp. 21% vs 4%; p=0·029 and 55% vs 23%; p=0·004). DLCOc, FEV1 and FVC in percentage of predicted were lower in severely ill patients. Severely ill patients were more likely to show an abnormal 6MWT, lower HGS and lower self-reported ADL and condition. In conclusion, in patients recovering from COVID-19, residual abnormalities were frequently present three months after hospitalization and associated with impaired pulmonary and physical function. This association was even stronger in patients who had been admitted to the ICU.}, year = {2021} }
TY - JOUR T1 - Analysis of Pulmonary and Physical Function Three Months After Discharge for Moderate to Severe COVID-19 AU - Bas Floris Maria Van Raaij AU - Jordy Lauran Stöger AU - Maarten Sebastiaan Werkman AU - Michiel Alexander De Graaf AU - Maria Louisa Antoni AU - Geert Hendrik Groeneveld AU - Anna Helena Elvire Roukens AU - Frederikus Albertus Klok AU - Soerindra Rajen Soeniel Ramai AU - Jacomina Jessica Miranda Geelhoed Y1 - 2021/09/08 PY - 2021 N1 - https://doi.org/10.11648/j.jher.20210703.15 DO - 10.11648/j.jher.20210703.15 T2 - Journal of Health and Environmental Research JF - Journal of Health and Environmental Research JO - Journal of Health and Environmental Research SP - 145 EP - 153 PB - Science Publishing Group SN - 2472-3592 UR - https://doi.org/10.11648/j.jher.20210703.15 AB - Pulmonary fibrosis with persistent physiological deficit is a previously described feature of patients recovering from coronaviruses. Long-term health consequences of COVID-19 are still largely unknown. We aimed to evaluate whether CT abnormalities persist in COVID-19 survivors three months after discharge, and whether the amount of affected lung tissue correlates with pulmonary and physical function. Therefore, we evaluated patients three months after discharge at our outpatient clinic. All patients underwent pulmonary function testing, high resolution chest CT, six-minute walk test and handgrip strength test. We compared severely ill patients to moderately ill patients, whom respectively received treatment at the Intensive Care Unit and the general ward. In total 84 patients were included with a median age of 61·4±12·9 years of whom 53 were male. 50 patients had moderate disease and 34 were severely ill. 66 patients had residual abnormalities on follow-up chest CT. Reticulation and curvilinear bands were more frequent in severely ill patients (resp. 21% vs 4%; p=0·029 and 55% vs 23%; p=0·004). DLCOc, FEV1 and FVC in percentage of predicted were lower in severely ill patients. Severely ill patients were more likely to show an abnormal 6MWT, lower HGS and lower self-reported ADL and condition. In conclusion, in patients recovering from COVID-19, residual abnormalities were frequently present three months after hospitalization and associated with impaired pulmonary and physical function. This association was even stronger in patients who had been admitted to the ICU. VL - 7 IS - 3 ER -